Medical Action Industries Inc. (NASDAQ:MDCI), a leading supplier of medical and surgical disposable products, today announced that it will not be presenting at the 2008 UBS Global Life Sciences Conference, as previously scheduled at 8:30am Monday, September 22, 2008.

“We regret the need to cancel our presentation in favor of business matters,” said Medical Action’s CEO and President Paul D. Meringolo, “and we look forward to the possibility of appearing at future conferences.”

Medical Action is a diversified manufacturer of disposable medical devices. Its products are marketed primarily to acute care facilities in domestic and certain international markets. Further, Medical Action has expanded its target market to include physician, dental and veterinary office, out-patient surgery centers, long-term care facilities and laboratories. Medical Action is a leading manufacturer and distributor of many of its products in the markets it competes in. The Company’s products are marketed nationally by its direct sales personnel and extensive network of healthcare distributors. Medical Action has preferred vendor agreements with national and regional distributors, as well as sole and multi source agreements with group purchasing organizations. The Company’s common stock trades on the NASDAQ Global Select Market under the symbol MDCI and is included in the Russell 2000 Index.

This news release contains forward-looking statements that involve risks and uncertainties regarding Medical Action’s operations and future results. Please see the Company’s filings with the Securities and Exchange Commission, including, without limitation, the Company’s Form 10-K and Form 10-Qs, which identify specific factors that would cause actual results or events to differ materially from those described in the forward-looking statements.

Medical Action Industries Inc.
Charles L. Kelly, Jr., 631-231-4600
Chief Financial Officer